News
LVZPF
4.350
NaN%
--
2026 Third-Quarter Dividend Update
TipRanks · 11/13 13:07
Livzon Announces 2026 Second Extraordinary General Meeting Results
TipRanks · 11/12 13:33
Livzon Pharmaceutical Group Lists Current Board and Committee Roles
TipRanks · 11/12 13:33
Livzon Updates 2026 Third-Quarter Dividend Details
TipRanks · 11/12 13:33
Livzon Agrees to Acquire Additional Xinbeijiang Pharma Shares
TipRanks · 11/11 12:37
CICC Reaffirms Their Buy Rating on Livzon Pharmaceutical Group (LVZPF)
TipRanks · 10/30 00:27
Livzon MABPharm Wins NMPA Nod for Next-Generation Anti-FXI Anticoagulant Trial
TipRanks · 10/27 09:08
Livzon Unit Wins NMPA Nod for Trial of New Vestibular Migraine Remedy
TipRanks · 10/27 09:08
Livzon Unit Wins NMPA Approval for Classical TCM Wandai Tang Granules
TipRanks · 10/27 09:08
Livzon Pharma Sets Q3 2026 Dividend Plan for A and H Shareholders
TipRanks · 10/23 09:09
Livzon Pharmaceutical Declares Third-Quarter Cash Dividend for 2026
TipRanks · 10/23 09:09
Livzon Pharmaceutical Sees Profit and Revenue Drop in Q3 2026
TipRanks · 10/23 08:39
Livzon Pharmaceutical Sets EGM to Approve Dividend and Long-Term Shareholder Return Plan
TipRanks · 10/23 08:39
Livzon Pharmaceutical Group Unveils Three-Year Shareholder Return Plan
TipRanks · 10/23 08:39
Livzon Pharmaceutical Schedules Board Meeting to Review Q3 Results and Potential Dividend
TipRanks · 10/12 09:11
Livzon Pharmaceutical Addresses Unusual Share Price Volatility
TipRanks · 09/29 13:11
Livzon Wins NMPA Approval for Three‑Month Leuprorelin Microsphere Injection
TipRanks · 09/29 11:08
Livzon Pharma Updates Terms of 2026 Special Interim Dividend
TipRanks · 09/25 08:37
Livzon Pharmaceutical Shareholders Approve EGM Resolution, Clearing Way for Special Dividend
TipRanks · 09/24 11:44
Livzon Pharmaceutical Announces Special Interim Dividend for H Shareholders
TipRanks · 09/24 11:44
More
Webull provides a variety of real-time LVZPF stock news. You can receive the latest news about Livzon Pharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About LVZPF
Livzon Pharmaceutical Group Inc is a China-based company principally engaged in the research, development, production and sale of pharmaceutical products. The Company's main businesses include chemical drug preparations, biological products, active pharmaceutical ingredients and intermediates, traditional Chinese medicine preparations, diagnostic reagents and equipment, commercial development and functional management. The Company's main products include Ilaprazole (Ilaprazole Enteric-Coated Tablets and Ilaprazole Sodium for Injection), a series of Bismuth Potassium Citrate products, Rabeprazole Sodium Enteric-Coated Capsules, Weisanlian (Bismuth Potassium Citrate Tablets/Tinidazole Tablets/Clarithromycin Tablets), Leuprorelin Acetate Microspheres for Injection, Urofollitropin for Injection, Menotropins for Injection, Voriconazole for Injection and others. The Company mainly operates its businesses in the domestic and overseas markets.